SureTrader Advertisement PRTC
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
 
Followed By 469
Posts 76,651
Boards Moderated 3
Alias Born 03/31/08
160x600 placeholder
Dow Rallies Nearly 200 Points As Banks, Tech Stocks March Higher
New home sales surge in April The Dow Jones Industrial Average jumped by nearly 200 points as a rally in financial and technology shares...
Top Equities Stories Of The Day
Bayer Lays Out Offer for Monsanto -- WSJ
J.P. Morgan Private Bank Lays Off Nearly 100 Employees
Court Tosses Crisis-Era Fraud Fine -- WSJ
Facebook Shifts Topics Feature Amid Bias Fears--update
Shanda Group Accumulates 11.7% LendingClub Stake
Samsung Targets U.S. Drug Market With Remicade Knockoff
Nokia to Return to Cellphones Via Licensing Pact -- Update
Sony Expects Deeper Loss for Image-Sensor Business
dDT   Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 83010 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist